These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 18207611)

  • 1. N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
    Baek RC; Kasperzyk JL; Platt FM; Seyfried TN
    Neurochem Int; 2008 May; 52(6):1125-33. PubMed ID: 18207611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
    Kasperzyk JL; El-Abbadi MM; Hauser EC; D'Azzo A; Platt FM; Seyfried TN
    J Neurochem; 2004 May; 89(3):645-53. PubMed ID: 15086521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.
    Andersson U; Smith D; Jeyakumar M; Butters TD; Borja MC; Dwek RA; Platt FM
    Neurobiol Dis; 2004 Aug; 16(3):506-15. PubMed ID: 15262262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice.
    Denny CA; Heinecke KA; Kim YP; Baek RC; Loh KS; Butters TD; Bronson RT; Platt FM; Seyfried TN
    J Neurochem; 2010 Jun; 113(6):1525-35. PubMed ID: 20374428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice.
    Arthur JR; Lee JP; Snyder EY; Seyfried TN
    Neurochem Res; 2012 Jun; 37(6):1335-43. PubMed ID: 22367451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates.
    Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Kuwahara J; Yamanaka S; Itoh K
    J Neurochem; 2005 Mar; 92(6):1497-507. PubMed ID: 15748167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic correction in microglia derived from Sandhoff disease model mice.
    Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Itoh K
    J Neurochem; 2005 Sep; 94(6):1631-8. PubMed ID: 16092933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of caloric restriction on motor behavior, longevity, and brain lipid composition in Sandhoff disease mice.
    Denny CA; Kasperzyk JL; Gorham KN; Bronson RT; Seyfried TN
    J Neurosci Res; 2006 May; 83(6):1028-38. PubMed ID: 16521125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversion of the biochemical defects in murine embryonic Sandhoff neurons using a bicistronic lentiviral vector encoding hexosaminidase alpha and beta.
    Arfi A; Zisling R; Richard E; Batista L; Poenaru L; Futerman AH; Caillaud C
    J Neurochem; 2006 Mar; 96(6):1572-9. PubMed ID: 16441513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of abnormal growth in astrocytes derived from a mouse model of GM2 gangliosidosis.
    Kawashima N; Tsuji D; Okuda T; Itoh K; Nakayama K
    J Neurochem; 2009 Nov; 111(4):1031-41. PubMed ID: 19765188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethylenedioxy-PIP2 oxalate reduces ganglioside storage in juvenile Sandhoff disease mice.
    Arthur JR; Wilson MW; Larsen SD; Rockwell HE; Shayman JA; Seyfried TN
    Neurochem Res; 2013 Apr; 38(4):866-75. PubMed ID: 23417430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin.
    Pelled D; Lloyd-Evans E; Riebeling C; Jeyakumar M; Platt FM; Futerman AH
    J Biol Chem; 2003 Aug; 278(32):29496-501. PubMed ID: 12756243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours.
    Ranes MK; El-Abbadi M; Manfredi MG; Mukherjee P; Platt FM; Seyfried TN
    Br J Cancer; 2001 Apr; 84(8):1107-14. PubMed ID: 11308262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin.
    Jeyakumar M; Smith DA; Williams IM; Borja MC; Neville DC; Butters TD; Dwek RA; Platt FM
    Ann Neurol; 2004 Nov; 56(5):642-9. PubMed ID: 15505823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice.
    Itakura T; Kuroki A; Ishibashi Y; Tsuji D; Kawashita E; Higashine Y; Sakuraba H; Yamanaka S; Itoh K
    Biol Pharm Bull; 2006 Aug; 29(8):1564-9. PubMed ID: 16880605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin.
    Jeyakumar M; Butters TD; Cortina-Borja M; Hunnam V; Proia RL; Perry VH; Dwek RA; Platt FM
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6388-93. PubMed ID: 10339597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous administration of scAAV9-Hexb normalizes lifespan and prevents pathology in Sandhoff disease mice.
    Niemir N; Rouvière L; Besse A; Vanier MT; Dmytrus J; Marais T; Astord S; Puech JP; Panasyuk G; Cooper JD; Barkats M; Caillaud C
    Hum Mol Genet; 2018 Mar; 27(6):954-968. PubMed ID: 29325092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipid synthesis is decreased in neuronal tissue in a mouse model of Sandhoff disease.
    Buccoliero R; Bodennec J; Van Echten-Deckert G; Sandhoff K; Futerman AH
    J Neurochem; 2004 Jul; 90(1):80-8. PubMed ID: 15198669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease.
    Baek RC; Martin DR; Cox NR; Seyfried TN
    Lipids; 2009 Mar; 44(3):197-205. PubMed ID: 19034545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration.
    Kyrkanides S; Miller JH; Brouxhon SM; Olschowka JA; Federoff HJ
    Brain Res Mol Brain Res; 2005 Feb; 133(2):286-98. PubMed ID: 15710246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.